0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gemcitabine Hydrochloride Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-32G15045
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gemcitabine Hydrochloride Market Insights Forecast to 2029
BUY CHAPTERS

Global Gemcitabine Hydrochloride Market Research Report 2025

Code: QYRE-Auto-32G15045
Report
January 2025
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gemcitabine Hydrochloride Market

The global market for Gemcitabine Hydrochloride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gemcitabine hydrochloride is a chemotherapy drug used to treat various types of cancer, including pancreatic, lung, breast, ovarian, and bladder cancer. It is a nucleoside analogue that interferes with the growth and spread of cancer cells in the body. Gemcitabine hydrochloride is typically administered intravenously and works by inhibiting the synthesis of DNA and RNA, thereby preventing cancer cells from dividing and multiplying. It is often used in combination with other chemotherapy drugs to enhance its effectiveness. Common side effects of gemcitabine hydrochloride include nausea, vomiting, fatigue, and low blood cell counts.
North American market for Gemcitabine Hydrochloride is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gemcitabine Hydrochloride is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gemcitabine Hydrochloride include Hubei Banbantian Pharmaceutical, Shandong Anhong Pharmaceutical, Shanghai Acebright Pharmaceuticals, Jiangsu Chia Tai Qingjiang Pharmaceutical, ScinoPharm Taiwan, Intas Pharmaceuticals, Euticals, Gland Pharma, SMS Pharmaceuticals, Cipla, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gemcitabine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Hydrochloride.
The Gemcitabine Hydrochloride market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gemcitabine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gemcitabine Hydrochloride Market Report

Report Metric Details
Report Name Gemcitabine Hydrochloride Market
by Type
by Application
  • Cancer
  • Tumor
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hubei Banbantian Pharmaceutical, Shandong Anhong Pharmaceutical, Shanghai Acebright Pharmaceuticals, Jiangsu Chia Tai Qingjiang Pharmaceutical, ScinoPharm Taiwan, Intas Pharmaceuticals, Euticals, Gland Pharma, SMS Pharmaceuticals, Cipla, Shilpa Medicare, Fresenius Kabi Oncology, Dr Reddy's Laboratories, Teva Pharmaceutical Industries, Hetero Drugs, Emcure Pharmaceuticals, Cadila Pharmaceuticals, Aarti Drugs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gemcitabine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Gemcitabine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Gemcitabine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gemcitabine Hydrochloride Market report?

Ans: The main players in the Gemcitabine Hydrochloride Market are Hubei Banbantian Pharmaceutical, Shandong Anhong Pharmaceutical, Shanghai Acebright Pharmaceuticals, Jiangsu Chia Tai Qingjiang Pharmaceutical, ScinoPharm Taiwan, Intas Pharmaceuticals, Euticals, Gland Pharma, SMS Pharmaceuticals, Cipla, Shilpa Medicare, Fresenius Kabi Oncology, Dr Reddy's Laboratories, Teva Pharmaceutical Industries, Hetero Drugs, Emcure Pharmaceuticals, Cadila Pharmaceuticals, Aarti Drugs

What are the Application segmentation covered in the Gemcitabine Hydrochloride Market report?

Ans: The Applications covered in the Gemcitabine Hydrochloride Market report are Cancer, Tumor

What are the Type segmentation covered in the Gemcitabine Hydrochloride Market report?

Ans: The Types covered in the Gemcitabine Hydrochloride Market report are Powder, Solvent

Recommended Reports

Cancer Therapeutics

Hydrochloride APIs

Cancer Subtypes

1 Gemcitabine Hydrochloride Market Overview
1.1 Product Definition
1.2 Gemcitabine Hydrochloride by Type
1.2.1 Global Gemcitabine Hydrochloride Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Powder
1.2.3 Solvent
1.3 Gemcitabine Hydrochloride by Application
1.3.1 Global Gemcitabine Hydrochloride Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Cancer
1.3.3 Tumor
1.4 Global Market Growth Prospects
1.4.1 Global Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Gemcitabine Hydrochloride Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Gemcitabine Hydrochloride Production Estimates and Forecasts (2020-2031)
1.4.4 Global Gemcitabine Hydrochloride Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gemcitabine Hydrochloride Production Market Share by Manufacturers (2020-2025)
2.2 Global Gemcitabine Hydrochloride Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Gemcitabine Hydrochloride, Industry Ranking, 2023 VS 2024
2.4 Global Gemcitabine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Gemcitabine Hydrochloride Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Gemcitabine Hydrochloride, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gemcitabine Hydrochloride, Product Offered and Application
2.8 Global Key Manufacturers of Gemcitabine Hydrochloride, Date of Enter into This Industry
2.9 Gemcitabine Hydrochloride Market Competitive Situation and Trends
2.9.1 Gemcitabine Hydrochloride Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gemcitabine Hydrochloride Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gemcitabine Hydrochloride Production by Region
3.1 Global Gemcitabine Hydrochloride Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Gemcitabine Hydrochloride Production Value by Region (2020-2031)
3.2.1 Global Gemcitabine Hydrochloride Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Gemcitabine Hydrochloride by Region (2026-2031)
3.3 Global Gemcitabine Hydrochloride Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Gemcitabine Hydrochloride Production Volume by Region (2020-2031)
3.4.1 Global Gemcitabine Hydrochloride Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Gemcitabine Hydrochloride by Region (2026-2031)
3.5 Global Gemcitabine Hydrochloride Market Price Analysis by Region (2020-2025)
3.6 Global Gemcitabine Hydrochloride Production and Value, Year-over-Year Growth
3.6.1 North America Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
4 Gemcitabine Hydrochloride Consumption by Region
4.1 Global Gemcitabine Hydrochloride Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Gemcitabine Hydrochloride Consumption by Region (2020-2031)
4.2.1 Global Gemcitabine Hydrochloride Consumption by Region (2020-2025)
4.2.2 Global Gemcitabine Hydrochloride Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Gemcitabine Hydrochloride Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Gemcitabine Hydrochloride Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gemcitabine Hydrochloride Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Gemcitabine Hydrochloride Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Gemcitabine Hydrochloride Production by Type (2020-2031)
5.1.1 Global Gemcitabine Hydrochloride Production by Type (2020-2025)
5.1.2 Global Gemcitabine Hydrochloride Production by Type (2026-2031)
5.1.3 Global Gemcitabine Hydrochloride Production Market Share by Type (2020-2031)
5.2 Global Gemcitabine Hydrochloride Production Value by Type (2020-2031)
5.2.1 Global Gemcitabine Hydrochloride Production Value by Type (2020-2025)
5.2.2 Global Gemcitabine Hydrochloride Production Value by Type (2026-2031)
5.2.3 Global Gemcitabine Hydrochloride Production Value Market Share by Type (2020-2031)
5.3 Global Gemcitabine Hydrochloride Price by Type (2020-2031)
6 Segment by Application
6.1 Global Gemcitabine Hydrochloride Production by Application (2020-2031)
6.1.1 Global Gemcitabine Hydrochloride Production by Application (2020-2025)
6.1.2 Global Gemcitabine Hydrochloride Production by Application (2026-2031)
6.1.3 Global Gemcitabine Hydrochloride Production Market Share by Application (2020-2031)
6.2 Global Gemcitabine Hydrochloride Production Value by Application (2020-2031)
6.2.1 Global Gemcitabine Hydrochloride Production Value by Application (2020-2025)
6.2.2 Global Gemcitabine Hydrochloride Production Value by Application (2026-2031)
6.2.3 Global Gemcitabine Hydrochloride Production Value Market Share by Application (2020-2031)
6.3 Global Gemcitabine Hydrochloride Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hubei Banbantian Pharmaceutical
7.1.1 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Company Information
7.1.2 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.1.3 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hubei Banbantian Pharmaceutical Main Business and Markets Served
7.1.5 Hubei Banbantian Pharmaceutical Recent Developments/Updates
7.2 Shandong Anhong Pharmaceutical
7.2.1 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Company Information
7.2.2 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.2.3 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shandong Anhong Pharmaceutical Main Business and Markets Served
7.2.5 Shandong Anhong Pharmaceutical Recent Developments/Updates
7.3 Shanghai Acebright Pharmaceuticals
7.3.1 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.3.2 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.3.3 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Shanghai Acebright Pharmaceuticals Main Business and Markets Served
7.3.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates
7.4 Jiangsu Chia Tai Qingjiang Pharmaceutical
7.4.1 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Company Information
7.4.2 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.4.3 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Chia Tai Qingjiang Pharmaceutical Main Business and Markets Served
7.4.5 Jiangsu Chia Tai Qingjiang Pharmaceutical Recent Developments/Updates
7.5 ScinoPharm Taiwan
7.5.1 ScinoPharm Taiwan Gemcitabine Hydrochloride Company Information
7.5.2 ScinoPharm Taiwan Gemcitabine Hydrochloride Product Portfolio
7.5.3 ScinoPharm Taiwan Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.5.4 ScinoPharm Taiwan Main Business and Markets Served
7.5.5 ScinoPharm Taiwan Recent Developments/Updates
7.6 Intas Pharmaceuticals
7.6.1 Intas Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.6.2 Intas Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.6.3 Intas Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Intas Pharmaceuticals Main Business and Markets Served
7.6.5 Intas Pharmaceuticals Recent Developments/Updates
7.7 Euticals
7.7.1 Euticals Gemcitabine Hydrochloride Company Information
7.7.2 Euticals Gemcitabine Hydrochloride Product Portfolio
7.7.3 Euticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Euticals Main Business and Markets Served
7.7.5 Euticals Recent Developments/Updates
7.8 Gland Pharma
7.8.1 Gland Pharma Gemcitabine Hydrochloride Company Information
7.8.2 Gland Pharma Gemcitabine Hydrochloride Product Portfolio
7.8.3 Gland Pharma Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Gland Pharma Main Business and Markets Served
7.8.5 Gland Pharma Recent Developments/Updates
7.9 SMS Pharmaceuticals
7.9.1 SMS Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.9.2 SMS Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.9.3 SMS Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.9.4 SMS Pharmaceuticals Main Business and Markets Served
7.9.5 SMS Pharmaceuticals Recent Developments/Updates
7.10 Cipla
7.10.1 Cipla Gemcitabine Hydrochloride Company Information
7.10.2 Cipla Gemcitabine Hydrochloride Product Portfolio
7.10.3 Cipla Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Cipla Main Business and Markets Served
7.10.5 Cipla Recent Developments/Updates
7.11 Shilpa Medicare
7.11.1 Shilpa Medicare Gemcitabine Hydrochloride Company Information
7.11.2 Shilpa Medicare Gemcitabine Hydrochloride Product Portfolio
7.11.3 Shilpa Medicare Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shilpa Medicare Main Business and Markets Served
7.11.5 Shilpa Medicare Recent Developments/Updates
7.12 Fresenius Kabi Oncology
7.12.1 Fresenius Kabi Oncology Gemcitabine Hydrochloride Company Information
7.12.2 Fresenius Kabi Oncology Gemcitabine Hydrochloride Product Portfolio
7.12.3 Fresenius Kabi Oncology Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Fresenius Kabi Oncology Main Business and Markets Served
7.12.5 Fresenius Kabi Oncology Recent Developments/Updates
7.13 Dr Reddy's Laboratories
7.13.1 Dr Reddy's Laboratories Gemcitabine Hydrochloride Company Information
7.13.2 Dr Reddy's Laboratories Gemcitabine Hydrochloride Product Portfolio
7.13.3 Dr Reddy's Laboratories Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Dr Reddy's Laboratories Main Business and Markets Served
7.13.5 Dr Reddy's Laboratories Recent Developments/Updates
7.14 Teva Pharmaceutical Industries
7.14.1 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Company Information
7.14.2 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Product Portfolio
7.14.3 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Teva Pharmaceutical Industries Main Business and Markets Served
7.14.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.15 Hetero Drugs
7.15.1 Hetero Drugs Gemcitabine Hydrochloride Company Information
7.15.2 Hetero Drugs Gemcitabine Hydrochloride Product Portfolio
7.15.3 Hetero Drugs Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Hetero Drugs Main Business and Markets Served
7.15.5 Hetero Drugs Recent Developments/Updates
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.16.2 Emcure Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.16.3 Emcure Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Emcure Pharmaceuticals Main Business and Markets Served
7.16.5 Emcure Pharmaceuticals Recent Developments/Updates
7.17 Cadila Pharmaceuticals
7.17.1 Cadila Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.17.2 Cadila Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.17.3 Cadila Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Cadila Pharmaceuticals Main Business and Markets Served
7.17.5 Cadila Pharmaceuticals Recent Developments/Updates
7.18 Aarti Drugs
7.18.1 Aarti Drugs Gemcitabine Hydrochloride Company Information
7.18.2 Aarti Drugs Gemcitabine Hydrochloride Product Portfolio
7.18.3 Aarti Drugs Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Aarti Drugs Main Business and Markets Served
7.18.5 Aarti Drugs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gemcitabine Hydrochloride Industry Chain Analysis
8.2 Gemcitabine Hydrochloride Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gemcitabine Hydrochloride Production Mode & Process Analysis
8.4 Gemcitabine Hydrochloride Sales and Marketing
8.4.1 Gemcitabine Hydrochloride Sales Channels
8.4.2 Gemcitabine Hydrochloride Distributors
8.5 Gemcitabine Hydrochloride Customer Analysis
9 Gemcitabine Hydrochloride Market Dynamics
9.1 Gemcitabine Hydrochloride Industry Trends
9.2 Gemcitabine Hydrochloride Market Drivers
9.3 Gemcitabine Hydrochloride Market Challenges
9.4 Gemcitabine Hydrochloride Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Gemcitabine Hydrochloride Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Gemcitabine Hydrochloride Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Gemcitabine Hydrochloride Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Gemcitabine Hydrochloride Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Gemcitabine Hydrochloride Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Gemcitabine Hydrochloride Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Gemcitabine Hydrochloride Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Gemcitabine Hydrochloride, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Gemcitabine Hydrochloride as of 2024)
 Table 10. Global Market Gemcitabine Hydrochloride Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Gemcitabine Hydrochloride, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Gemcitabine Hydrochloride, Product Offered and Application
 Table 13. Global Key Manufacturers of Gemcitabine Hydrochloride, Date of Enter into This Industry
 Table 14. Global Gemcitabine Hydrochloride Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gemcitabine Hydrochloride Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Gemcitabine Hydrochloride Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Gemcitabine Hydrochloride Production Value Market Share by Region (2020-2025)
 Table 19. Global Gemcitabine Hydrochloride Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Gemcitabine Hydrochloride Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Gemcitabine Hydrochloride Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Gemcitabine Hydrochloride Production (Tons) by Region (2020-2025)
 Table 23. Global Gemcitabine Hydrochloride Production Market Share by Region (2020-2025)
 Table 24. Global Gemcitabine Hydrochloride Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Gemcitabine Hydrochloride Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Gemcitabine Hydrochloride Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Gemcitabine Hydrochloride Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Gemcitabine Hydrochloride Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Gemcitabine Hydrochloride Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Gemcitabine Hydrochloride Consumption Market Share by Region (2020-2025)
 Table 31. Global Gemcitabine Hydrochloride Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Gemcitabine Hydrochloride Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Gemcitabine Hydrochloride Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Gemcitabine Hydrochloride Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Gemcitabine Hydrochloride Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Gemcitabine Hydrochloride Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Gemcitabine Hydrochloride Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Gemcitabine Hydrochloride Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Gemcitabine Hydrochloride Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Gemcitabine Hydrochloride Production (Tons) by Type (2020-2025)
 Table 46. Global Gemcitabine Hydrochloride Production (Tons) by Type (2026-2031)
 Table 47. Global Gemcitabine Hydrochloride Production Market Share by Type (2020-2025)
 Table 48. Global Gemcitabine Hydrochloride Production Market Share by Type (2026-2031)
 Table 49. Global Gemcitabine Hydrochloride Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Gemcitabine Hydrochloride Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Gemcitabine Hydrochloride Production Value Market Share by Type (2020-2025)
 Table 52. Global Gemcitabine Hydrochloride Production Value Market Share by Type (2026-2031)
 Table 53. Global Gemcitabine Hydrochloride Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Gemcitabine Hydrochloride Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Gemcitabine Hydrochloride Production (Tons) by Application (2020-2025)
 Table 56. Global Gemcitabine Hydrochloride Production (Tons) by Application (2026-2031)
 Table 57. Global Gemcitabine Hydrochloride Production Market Share by Application (2020-2025)
 Table 58. Global Gemcitabine Hydrochloride Production Market Share by Application (2026-2031)
 Table 59. Global Gemcitabine Hydrochloride Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Gemcitabine Hydrochloride Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Gemcitabine Hydrochloride Production Value Market Share by Application (2020-2025)
 Table 62. Global Gemcitabine Hydrochloride Production Value Market Share by Application (2026-2031)
 Table 63. Global Gemcitabine Hydrochloride Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Gemcitabine Hydrochloride Price (US$/Ton) by Application (2026-2031)
 Table 65. Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Company Information
 Table 66. Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Specification and Application
 Table 67. Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Hubei Banbantian Pharmaceutical Main Business and Markets Served
 Table 69. Hubei Banbantian Pharmaceutical Recent Developments/Updates
 Table 70. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Company Information
 Table 71. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Specification and Application
 Table 72. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Shandong Anhong Pharmaceutical Main Business and Markets Served
 Table 74. Shandong Anhong Pharmaceutical Recent Developments/Updates
 Table 75. Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Company Information
 Table 76. Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Specification and Application
 Table 77. Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Shanghai Acebright Pharmaceuticals Main Business and Markets Served
 Table 79. Shanghai Acebright Pharmaceuticals Recent Developments/Updates
 Table 80. Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Company Information
 Table 81. Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Specification and Application
 Table 82. Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Jiangsu Chia Tai Qingjiang Pharmaceutical Main Business and Markets Served
 Table 84. Jiangsu Chia Tai Qingjiang Pharmaceutical Recent Developments/Updates
 Table 85. ScinoPharm Taiwan Gemcitabine Hydrochloride Company Information
 Table 86. ScinoPharm Taiwan Gemcitabine Hydrochloride Specification and Application
 Table 87. ScinoPharm Taiwan Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. ScinoPharm Taiwan Main Business and Markets Served
 Table 89. ScinoPharm Taiwan Recent Developments/Updates
 Table 90. Intas Pharmaceuticals Gemcitabine Hydrochloride Company Information
 Table 91. Intas Pharmaceuticals Gemcitabine Hydrochloride Specification and Application
 Table 92. Intas Pharmaceuticals Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Intas Pharmaceuticals Main Business and Markets Served
 Table 94. Intas Pharmaceuticals Recent Developments/Updates
 Table 95. Euticals Gemcitabine Hydrochloride Company Information
 Table 96. Euticals Gemcitabine Hydrochloride Specification and Application
 Table 97. Euticals Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Euticals Main Business and Markets Served
 Table 99. Euticals Recent Developments/Updates
 Table 100. Gland Pharma Gemcitabine Hydrochloride Company Information
 Table 101. Gland Pharma Gemcitabine Hydrochloride Specification and Application
 Table 102. Gland Pharma Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Gland Pharma Main Business and Markets Served
 Table 104. Gland Pharma Recent Developments/Updates
 Table 105. SMS Pharmaceuticals Gemcitabine Hydrochloride Company Information
 Table 106. SMS Pharmaceuticals Gemcitabine Hydrochloride Specification and Application
 Table 107. SMS Pharmaceuticals Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. SMS Pharmaceuticals Main Business and Markets Served
 Table 109. SMS Pharmaceuticals Recent Developments/Updates
 Table 110. Cipla Gemcitabine Hydrochloride Company Information
 Table 111. Cipla Gemcitabine Hydrochloride Specification and Application
 Table 112. Cipla Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Cipla Main Business and Markets Served
 Table 114. Cipla Recent Developments/Updates
 Table 115. Shilpa Medicare Gemcitabine Hydrochloride Company Information
 Table 116. Shilpa Medicare Gemcitabine Hydrochloride Specification and Application
 Table 117. Shilpa Medicare Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Shilpa Medicare Main Business and Markets Served
 Table 119. Shilpa Medicare Recent Developments/Updates
 Table 120. Fresenius Kabi Oncology Gemcitabine Hydrochloride Company Information
 Table 121. Fresenius Kabi Oncology Gemcitabine Hydrochloride Specification and Application
 Table 122. Fresenius Kabi Oncology Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Fresenius Kabi Oncology Main Business and Markets Served
 Table 124. Fresenius Kabi Oncology Recent Developments/Updates
 Table 125. Dr Reddy's Laboratories Gemcitabine Hydrochloride Company Information
 Table 126. Dr Reddy's Laboratories Gemcitabine Hydrochloride Specification and Application
 Table 127. Dr Reddy's Laboratories Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Dr Reddy's Laboratories Main Business and Markets Served
 Table 129. Dr Reddy's Laboratories Recent Developments/Updates
 Table 130. Teva Pharmaceutical Industries Gemcitabine Hydrochloride Company Information
 Table 131. Teva Pharmaceutical Industries Gemcitabine Hydrochloride Specification and Application
 Table 132. Teva Pharmaceutical Industries Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Teva Pharmaceutical Industries Main Business and Markets Served
 Table 134. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 135. Hetero Drugs Gemcitabine Hydrochloride Company Information
 Table 136. Hetero Drugs Gemcitabine Hydrochloride Specification and Application
 Table 137. Hetero Drugs Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Hetero Drugs Main Business and Markets Served
 Table 139. Hetero Drugs Recent Developments/Updates
 Table 140. Emcure Pharmaceuticals Gemcitabine Hydrochloride Company Information
 Table 141. Emcure Pharmaceuticals Gemcitabine Hydrochloride Specification and Application
 Table 142. Emcure Pharmaceuticals Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. Emcure Pharmaceuticals Main Business and Markets Served
 Table 144. Emcure Pharmaceuticals Recent Developments/Updates
 Table 145. Cadila Pharmaceuticals Gemcitabine Hydrochloride Company Information
 Table 146. Cadila Pharmaceuticals Gemcitabine Hydrochloride Specification and Application
 Table 147. Cadila Pharmaceuticals Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 148. Cadila Pharmaceuticals Main Business and Markets Served
 Table 149. Cadila Pharmaceuticals Recent Developments/Updates
 Table 150. Aarti Drugs Gemcitabine Hydrochloride Company Information
 Table 151. Aarti Drugs Gemcitabine Hydrochloride Specification and Application
 Table 152. Aarti Drugs Gemcitabine Hydrochloride Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 153. Aarti Drugs Main Business and Markets Served
 Table 154. Aarti Drugs Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Gemcitabine Hydrochloride Distributors List
 Table 158. Gemcitabine Hydrochloride Customers List
 Table 159. Gemcitabine Hydrochloride Market Trends
 Table 160. Gemcitabine Hydrochloride Market Drivers
 Table 161. Gemcitabine Hydrochloride Market Challenges
 Table 162. Gemcitabine Hydrochloride Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gemcitabine Hydrochloride
 Figure 2. Global Gemcitabine Hydrochloride Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Gemcitabine Hydrochloride Market Share by Type: 2024 VS 2031
 Figure 4. Powder Product Picture
 Figure 5. Solvent Product Picture
 Figure 6. Global Gemcitabine Hydrochloride Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Gemcitabine Hydrochloride Market Share by Application: 2024 VS 2031
 Figure 8. Cancer
 Figure 9. Tumor
 Figure 10. Global Gemcitabine Hydrochloride Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Gemcitabine Hydrochloride Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Gemcitabine Hydrochloride Production Capacity (Tons) & (2020-2031)
 Figure 13. Global Gemcitabine Hydrochloride Production (Tons) & (2020-2031)
 Figure 14. Global Gemcitabine Hydrochloride Average Price (US$/Ton) & (2020-2031)
 Figure 15. Gemcitabine Hydrochloride Report Years Considered
 Figure 16. Gemcitabine Hydrochloride Production Share by Manufacturers in 2024
 Figure 17. Global Gemcitabine Hydrochloride Production Value Share by Manufacturers (2024)
 Figure 18. Gemcitabine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Gemcitabine Hydrochloride Revenue in 2024
 Figure 20. Global Gemcitabine Hydrochloride Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Gemcitabine Hydrochloride Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Gemcitabine Hydrochloride Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 23. Global Gemcitabine Hydrochloride Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Gemcitabine Hydrochloride Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Gemcitabine Hydrochloride Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Gemcitabine Hydrochloride Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Gemcitabine Hydrochloride Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Gemcitabine Hydrochloride Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Gemcitabine Hydrochloride Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 31. North America Gemcitabine Hydrochloride Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. Canada Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Europe Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Gemcitabine Hydrochloride Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. France Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. U.K. Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Italy Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Russia Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Asia Pacific Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Gemcitabine Hydrochloride Consumption Market Share by Region (2020-2031)
 Figure 43. China Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Japan Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. South Korea Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. China Taiwan Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Southeast Asia Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. India Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Brazil Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Turkey Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. GCC Countries Gemcitabine Hydrochloride Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Global Production Market Share of Gemcitabine Hydrochloride by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Gemcitabine Hydrochloride by Type (2020-2031)
 Figure 57. Global Gemcitabine Hydrochloride Price (US$/Ton) by Type (2020-2031)
 Figure 58. Global Production Market Share of Gemcitabine Hydrochloride by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Gemcitabine Hydrochloride by Application (2020-2031)
 Figure 60. Global Gemcitabine Hydrochloride Price (US$/Ton) by Application (2020-2031)
 Figure 61. Gemcitabine Hydrochloride Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India